TREMELIMUMAB

Clinical trials for TREMELIMUMAB explained in plain language.

Never miss a new study

Get alerted when new TREMELIMUMAB trials appear

Sign up with your email to follow new studies for TREMELIMUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to boost liver cancer survival

Disease control Recruiting now

This phase 2 trial tests a new combination treatment for people with advanced liver cancer that cannot be removed by surgery. It combines precise proton radiation with two immunotherapy drugs, tremelimumab and durvalumab. The goal is to see if this approach is safe and works bett…

Matched conditions: TREMELIMUMAB

Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control

Last updated Jun 26, 2026 16:22 UTC

TREMELIMUMAB

Get alerted when new TREMELIMUMAB trials appear

New combo therapy aims to boost liver cancer survival